PROPREQTIVE
Live / Applied — First extension granted (statement of use) (as of 14 Feb 2026)
What this means for you
Not registered yet, but its 24 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99017522
- Mark type
- Stylized text
- Filed
- 24 Jan 2025
- Published for opposition
- 23 Sept 2025
- Attorney of record
- Joshua S. Jarvis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immune system related diseases and disorders, complement-mediated diseases and disorders, and neurological diseases and disorders; pharmaceutical preparations for the treatment of Guillain-Barré syndrome.
Owner
- Annexon, Inc., Brisbane, CA, US
- Annexon, Inc., Brisbane, CA, US
Prosecution history
- 28 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2026 — SOU EXTENSION 1 GRANTED
- 13 Feb 2026 — SOU EXTENSION 1 FILED
- 13 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Sept 2025 — PUBLISHED FOR OPPOSITION
- 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Aug 2025 — ASSIGNED TO EXAMINER
- 22 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Jan 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Jan 2025 — NEW APPLICATION ENTERED